Delaugerre, C., Flandre, P., Chaix, M. L., Ghosn, J., Raffi, F., Dellamonica, P., . . . Rouzioux, C. (2009). Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir plus Zidovudine and Lamivudine Triple Therapy. American Society for Microbiology (ASM).
Chicago ZitierstilDelaugerre, Constance, et al. Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir Plus Zidovudine and Lamivudine Triple Therapy. American Society for Microbiology (ASM), 2009.
MLA ZitierstilDelaugerre, Constance, et al. Protease Inhibitor Resistance Analysis in the MONARK Trial Comparing First-Line Lopinavir-Ritonavir Monotherapy to Lopinavir-Ritonavir Plus Zidovudine and Lamivudine Triple Therapy. American Society for Microbiology (ASM), 2009.